Radiologic observation: Repair of focal bone erosions after humanized antitumor necrosis factor antibody adalimumab therapy in a patient with rheumatoid arthritis

Clinical Rheumatology

Volumn 29, Issue 2, 2010, Pages 211-213

  Ahn, Inhye E ^a   Ju, Ji Hyeon ^a   Park, Sung Hwan ^a   Kim, Ho Youn ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Adalimumab; Bone resorption; Osteoclasts; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

ADALIMUMAB; CALCIUM; CYCLOOXYGENASE 2 INHIBITOR; FOLIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISOLONE; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTHRALGIA; ARTICLE; BONE DENSITY; BONE DESTRUCTION; BONE EROSION; BONE REMODELING; BRONCHOPNEUMONIA; CASE REPORT; DRUG WITHDRAWAL; FEMALE; FEMUR; HAND BONE; HAND RADIOGRAPHY; HUMAN; JOINT CAVITY; MAINTENANCE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; RHEUMATOID ARTHRITIS; SPINE; TRABECULAR BONE; WRIST; DRUG ANTAGONISM; FINGER JOINT; OSTEOLYSIS; RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE RESORPTION; FEMALE; FINGER JOINT; HUMANS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949901126     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1293-x     Document Type: Article

References (8)

1. U Møller Døhn A Boonen ML Hetland MS Hansen LS Knudsen A Hansen OR Madsen M Hasselquist JM Møller M Ostergaard 2008 Erosive progression is minimal, but erosion healing rare, in rheumatoid arthritis patients treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure Ann Rheum Dis 68 1585 1590 10.1136/ard.2008.097048 19019887
2. van der Linden MP, Boja R, Klarenbeek NB, Huizinga TW, van der Heijde DM, van der Helm-van Mil AH (2009) Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristics in a large inception cohort. Ann Rheum Dis (in press)
3. H Ideguchi S Ohno H Hattori A Senuma Y Ishigatsubo 2006 Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs Arthritis Res Ther 8 3 R76 10.1186/ar1943 16646983
4. EM Gravallese SR Goldring 2000 Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis Arthritis Rheum 43 2143 2151 10.1002/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S 1:CAS:528:DC%2BD3cXnslWjsrs%3D 11037873
5. K Sato A Suematsu K Okamoto A Yamaguchi Y Morishita Y Kadono S Tanaka T Kodama S Akira Y Iwakura DJ Cua H Takayanagi 2006 Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J Exp Med 203 12 2673 2682 10.1084/jem.20061775 1:CAS:528: DC%2BD28Xht12htLfJ 17088434 (Pubitemid 44833343)
6. DM van der Heijde PL van Riel IH Nuver-Zwart FW Gribnau LB van de Putte 1989 Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis Lancet 1 8646 1036 1038 2565997
7. DJ Shealy PH Wooley E Emmell A Volk A Rosenberg G Treacy CL Wagner L Mayton DE Griswold XY Song 2002 Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice Arthritis Res 4 5 R7 10.1186/ar430 12223110
8. K Redlich B Görtz S Hayer J Zwerina N Doerr P Kostenuik H Bergmeister G Kollias G Steiner JS Smolen G Schett 2004 Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis Am J Pathol 164 2 543 555 1:CAS:528:DC%2BD2cXhsFGqsLg%3D 14742260